Tommaso Colangelo

1.1k total citations
27 papers, 637 citations indexed

About

Tommaso Colangelo is a scholar working on Molecular Biology, Cancer Research and Endocrine and Autonomic Systems. According to data from OpenAlex, Tommaso Colangelo has authored 27 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cancer Research and 5 papers in Endocrine and Autonomic Systems. Recurrent topics in Tommaso Colangelo's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circadian rhythm and melatonin (5 papers). Tommaso Colangelo is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circadian rhythm and melatonin (5 papers). Tommaso Colangelo collaborates with scholars based in Italy, United Kingdom and Germany. Tommaso Colangelo's co-authors include Vittorio Colantuoni, Lina Sabatino, Gianluigi Mazzoccoli, Carolina Votino, Fabrizio Bianchi, Massimo Pancione, Alessandra Fucci, Livio Muccillo, Elisa Dama and Nicola Forte and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Tommaso Colangelo

26 papers receiving 635 citations

Peers

Tommaso Colangelo
Michael Batie United Kingdom
Je Yeong Ko South Korea
Xia Qiu China
Nolan G. Ericson United States
Tommaso Colangelo
Citations per year, relative to Tommaso Colangelo Tommaso Colangelo (= 1×) peers Xiaofang Ying

Countries citing papers authored by Tommaso Colangelo

Since Specialization
Citations

This map shows the geographic impact of Tommaso Colangelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommaso Colangelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommaso Colangelo more than expected).

Fields of papers citing papers by Tommaso Colangelo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tommaso Colangelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommaso Colangelo. The network helps show where Tommaso Colangelo may publish in the future.

Co-authorship network of co-authors of Tommaso Colangelo

This figure shows the co-authorship network connecting the top 25 collaborators of Tommaso Colangelo. A scholar is included among the top collaborators of Tommaso Colangelo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tommaso Colangelo. Tommaso Colangelo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colangelo, Tommaso, et al.. (2025). Unveiling the origin and functions of diagnostic circulating microRNAs in lung cancer. British Journal of Cancer. 132(10). 947–956.
2.
Mattoscio, Domenico, Haiqing Bai, Tommaso Colangelo, et al.. (2025). Inflammation and epithelial–mesenchymal transition in a CFTR ‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip. FEBS Journal. 292(19). 5086–5104. 1 indexed citations
3.
Pannone, Giuseppe, Maria Carmela Pedicillo, Maurizio Municinò, et al.. (2024). The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism. Cells. 13(10). 854–854. 2 indexed citations
4.
Sangineto, Moris, Tommaso Colangelo, Archana Moola, et al.. (2024). Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis. Cell Reports Medicine. 5(5). 101564–101564. 11 indexed citations
5.
Pedicillo, Maria Carmela, Rosanna Zamparese, Tommaso Colangelo, et al.. (2023). The Role of Toll-like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3. International Journal of Molecular Sciences. 24(17). 13259–13259. 10 indexed citations
6.
Colangelo, Tommaso, et al.. (2023). Role of the Circadian Gas-Responsive Hemeprotein NPAS2 in Physiology and Pathology. Biology. 12(10). 1354–1354. 7 indexed citations
7.
Colangelo, Tommaso, Annalucia Carbone, Angela Relógio, et al.. (2023). The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia. Journal of Experimental & Clinical Cancer Research. 42(1). 218–218. 8 indexed citations
8.
Colangelo, Tommaso, Annalucia Carbone, Roberto Cuttano, et al.. (2022). Loss of circadian gene Timeless induces EMT and tumor progression in colorectal cancer via Zeb1-dependent mechanism. Cell Death and Differentiation. 29(8). 1552–1568. 26 indexed citations
9.
Cuttano, Roberto, Tommaso Colangelo, Juliana Guarize, et al.. (2022). miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response. Journal of Hematology & Oncology. 15(1). 178–178. 6 indexed citations
10.
Dama, Elisa, Roberto Cuttano, Tommaso Colangelo, et al.. (2021). Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype. Oncogene. 40(31). 4980–4991. 9 indexed citations
11.
Dama, Elisa, Tommaso Colangelo, M. Cremonesi, et al.. (2021). Biomarkers and Lung Cancer Early Detection: State of the Art. Cancers. 13(15). 3919–3919. 55 indexed citations
12.
Noguera, Nélida I., Tommaso Colangelo, Elisabetta De Marinis, et al.. (2020). Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 9(11). 2423–2423. 14 indexed citations
13.
Colangelo, Tommaso, Livio Muccillo, Maria Letizia Taddei, et al.. (2020). Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. British Journal of Cancer. 122(10). 1576–1576. 1 indexed citations
15.
Colangelo, Tommaso, Giovanna Polcaro, Livio Muccillo, et al.. (2016). Friend or foe?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1867(1). 1–18. 62 indexed citations
16.
Votino, Carolina, Tommaso Colangelo, Carmen Cerchia, et al.. (2016). The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands. Biochemical Pharmacology. 108. 22–35. 24 indexed citations
17.
Colangelo, Tommaso, Giovanna Polcaro, Livio Muccillo, et al.. (2016). The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells. Cell Death and Disease. 7(2). e2108–e2108. 61 indexed citations
18.
Mazzoccoli, Gianluigi, Mikko O. Laukkanen, Manlio Vinciguerra, Tommaso Colangelo, & Vittorio Colantuoni. (2015). A Timeless Link Between Circadian Patterns and Disease. Trends in Molecular Medicine. 22(1). 68–81. 45 indexed citations
19.
Panza, Anna, Carolina Votino, Annamaria Gentile, et al.. (2014). Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(6). 1225–1236. 26 indexed citations
20.
Colangelo, Tommaso, Alessandra Fucci, Carolina Votino, et al.. (2013). MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer. Neoplasia. 15(9). 1086–1099. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026